GSK and J&J back $1 billion biotech spin-off from Index Ventures
Posted onBy Ben Hirschler LONDON (Reuters) – Index Ventures, an early investor in technology hits like Skype and Dropbox, is spinning off its biotech portfolio into a new $1 billion (695 million pounds) business, with backing from drug giants GlaxoSmithKline and Johnson & Johnson . The new Medicxi Ventures business will be led by the existing […]